Navigation Links
Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil

    DUSSELDORF, Germany, January 11 /PRNewswire-FirstCall/ --
    - Expansion of Cooperation With Diabetes Leader Novo Nordisk
    - Important Step in the Worldwide Development of Medical Plastic Systems

The Gerresheimer Group has set up a new facility for medical plastic systems in Indaiatuba (Brazil). The plant is to commence operations early in 2010. On the basis of a long-term cooperation agreement with Novo Nordisk, components will be produced with state-of-the-art technology for insulin pen systems for diabetics.

Insulin pens are drug-delivery devices in ball-point pen format which allow diabetes patients to inject themselves with the regularly required insulin dose safely and almost painlessly. Novo Nordisk as the world's leading insulin producer has contracted Gerresheimer to manufacture components for its insulin pens. Novo Nordisk has a large insulin plant in Brazil which will in future be supplied locally by the new technology center of the Gerresheimer Group. For Gerresheimer this is already the fourth production plant in South America in addition to two existing plants for standardized pharma plastic packaging in Brazil and one in Argentina.

Apart from the new production facility in Brazil, Gerresheimer already has two other production facilities for pen systems in Europe.

"Cooperation with Novo Nordisk in Brazil is of substantial strategic importance for us. We support the customer in developing new markets and at the same time expand our technological base in South America," says Gerresheimer CEO Dr. Axel Herberg.

About Gerresheimer

Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled EUR1.06bn. The product portfolio ranges from pharma-ceu-tical vials made of glass and plastic through to complex drug-delivery systems for the pharma & healthcare industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.

    Contact Press

    Burkhard Lingenberg
    Director Corporate Communication & Marketing
    Phone +49-211-6181-250
    Fax +49-211-6181-241

    Contact Investor Relations

    Anke Linnartz
    Director Corporate Investor Relations
    Phone +49-211-6181-314
    Fax +49-211-6181-121

SOURCE Gerresheimer AG

SOURCE Gerresheimer AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Gerresheimer Holds its own in Difficult Environment
2. Gerresheimer Sells Technical Plastics Business
3. Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China
4. 2008 a Record Year for Gerresheimer
5. Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009
6. Gerresheimer Substantially Increases Quarterly Operating Profit
7. Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics
8. Gerresheimer Further Increases its Sales and Earnings Power
9. Gerresheimer Discontinues Marginal Operations
10. Moodys Raises Rating for Gerresheimer
11. Gerresheimer: Record Year in 2007 and Positive Outlook for 2008
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
Breaking Biology News(10 mins):